|
Volumn 88, Issue 2, 2001, Pages 235-240
|
Tumour necrosis factor inhibitors reduce the acute-phase response in hapten-induced colitis
a a a a b b,c
b
UCB PHARMA
(Belgium)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 2 MACROGLOBULIN;
CTN 3;
HAPTEN;
MONOCLONAL ANTIBODY CTN3;
PENTOXIFYLLINE;
TRINITROBENZENESULFONIC ACID;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR ANTIBODY;
UNCLASSIFIED DRUG;
ACUTE PHASE RESPONSE;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BODY WEIGHT;
COLITIS;
CONTROLLED STUDY;
DRUG EFFECT;
MALE;
NONHUMAN;
ORGAN WEIGHT;
PATHOGENESIS;
PRIORITY JOURNAL;
RAT;
ACUTE-PHASE REACTION;
ANIMALS;
ANTIBODIES;
COLITIS;
HAPTENS;
RATS;
RATS, WISTAR;
TRINITROBENZENESULFONIC ACID;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0035133014
PISSN: 00071323
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2168.2001.01646.x Document Type: Article |
Times cited : (14)
|
References (37)
|